Iambic Therapeutics Stock (NASDAQ:IAM)
Previous Close
$16.34
52W Range
$14.10 - $25.00
50D Avg
$19.69
200D Avg
$19.69
Market Cap
$146.06M
Avg Vol (3M)
$2.45M
Beta
-
Div Yield
-
IAM Company Profile
Iambic Therapeutics, Inc. develops AI driven platform for drug discovery. It combines proprietary AI-driven platforms with the expertise of experienced drug discovery scientists to identify, design, and optimize novel therapeutic candidates across a range of disease areas. The company was founded by Thomas Miller and Fred Manby on October 14, 2019 and is headquartered in San Diego, CA.